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Abstract
Objective—To evaluate the diagnostic performance of chest x-ray (CXR) compared to computed
tomography (CT) for detection of pulmonary opacities in adult emergency department (ED)
patients.
Methods—We conducted an observational cross sectional study of adult patients presenting to
12 EDs in the United States from July 1, 2003 through November 30, 2006 who underwent both
CXR and chest CT for routine clinical care. CXRs and CT scans performed on the same patient
were matched. CXRs and CT scans were interpreted by attending radiologists and classified as
containing pulmonary opacities if the final radiologist report noted opacity, infiltrate,
consolidation, pneumonia, or bronchopneumonia. Using CT as a criterion standard, the diagnostic
test characteristics of CXR to detect pulmonary opacities were calculated.
Results—The study cohort included 3,423 patients. Shortness of breath, chest pain and cough
were the most common complaints, with 96.1% of subjects reporting at least one of these
symptoms. Pulmonary opacities were visualized on 309 (9.0%) CXRs and 191 (5.6 %) CT scans.
CXR test characteristics for detection of pulmonary opacities included: sensitivity 43.5% (95% CI:
36.4%–50.8%); specificity 93.0% (95% CI: 92.1%–93.9%); positive predictive value 26.9% (95%
CI: 22.1%–32.2%); and negative predictive value 96.5% (95% CI: 95.8%–97.1%).
Conclusion—In this multicenter cohort of adult ED patients with acute cardiopulmonary
symptoms, CXR demonstrated poor sensitivity and positive predictive value for detecting
pulmonary opacities. Reliance on CXR to identify pneumonia may lead to significant rates of
misdiagnosis.
© 2012 Elsevier Inc. All rights reserved.
Corresponding Author: Wesley H. Self, MD MPH, Department of Emergency Medicine, Vanderbilt University School of Medicine,
1313 21st Ave South, 703 Oxford House, Nashville, TN 37232-4700, wesley.self@vanderbilt.edu.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
NIH Public Access
Author Manuscript
Am J Emerg Med. Author manuscript; available in PMC 2014 February 01.
Published in final edited form as:
Am J Emerg Med. 2013 February ; 31(2): 401–405. doi:10.1016/j.ajem.2012.08.041.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Keywords
chest x-ray; computed tomography; pneumonia; emergency department; diagnostic testing
1. Introduction
A chest x-ray (CXR) is completed during approximately 18.5% of all emergency department
(ED) visits in the United States (US), with an estimated 20.4 million ED CXRs performed
annually.1 When evaluating patients with chest symptoms, such as shortness of breath, chest
pain and cough, emergency clinicians must decide if CXR findings are consistent with
pneumonia. Failure to promptly recognize and treat bacterial pneumonia may lead to
significant morbidity and mortality.2, 3 Meanwhile, inappropriate use of antibiotics for
respiratory symptoms not caused by bacterial infection is likely a major contributor to the
development of antibiotic resistance.4–6 Furthermore, attributing a patient’s symptoms to
pneumonia based on CXR results when, in fact, pneumonia is not present may lead to
diagnostic anchoring and failure to recognize the patient’s true illness.7
Pulmonary opacitiesareas of increased attenuation visualized within the lung fields on chest
imaging,8–9 are commonly used as criteria to support a diagnosis of pneumonia.3, 10 Despite
CXR being used as the primary radiographic test to evaluate for pneumonia, the test
characteristics of CXR for detecting pneumonia are not well understood. Computed
tomography (CT) is a more precise technique for imaging the chest, but has not supplanted
CXR as the primary imaging test for pneumonia due to increased time, cost, and radiation
exposure associated with CT.11–13 However, comparing CXR to CT offers an opportunity to
evaluate the accuracy of CXR for demonstrating radiographic findings consistent with
pneumonia and to help inform clinicians how to use CXR results when considering a
diagnosis of pneumonia. The purpose of this study was to evaluate the diagnostic test
characteristics of CXR for detection of pulmonary opacities compared to a chest CT
criterion standard in adult ED patients.
2. Methods
We conducted an observational, multicenter, cross-sectional study of adult ED patients who
underwent both a CXR and chest CT as part of their evaluation. The diagnostic test
characteristics of CXR for detection of pulmonary opacities were calculated using a
concurrent chest CT as a criterion standard. The Institutional Review Board at all
participating sites approved this study.
2.1 Patients
The study consisted of a secondary analysis of a prospective cohort recruited in 12 US EDs
from July 1, 2003 through November 30, 2006. The cohort was initially recruited to study
the diagnostic evaluation of pulmonary embolism (PE) and has been previously
described.14, 15 Briefly, patients presenting to a study ED with acute symptoms were
enrolled if a treating clinician ordered a diagnostic test for PE, including a chest CT, D-
dimer assay, or ventilation/perfusion scan. Subjects were managed by emergency clinicians
independent of the study protocol. Enrolled subjects underwent a structured interview and
medical records review to obtain demographic and clinical data. For the current study, we
included subjects who underwent both a CXR and chest CT as part of their ED evaluation.
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2.2 Radiographic studies
All CXRs and chest CT scans were ordered by treating clinicians and interpreted by
attending radiologists as part of routine clinical care. For each subject, the first CXR
completed during his/her ED visit was matched to the first chest CT scan. Both single view
(anterior-posterior) and two-view (posterior-anterior/lateral) CXRs were included. All CT
scans included intravenous administration of iodinated contrast. Radiologists interpreted
these studies as routine CXRs and CT scans completed at their institutions and were able to
review the medical record and previous radiographic studies as part of standard clinical care.
Radiologists entered their final interpretation for each CXR and CT scan into the medical
record. Trained research assistants read the radiologist’s final interpretation and classified
CXRs and CT scans as having a pulmonary opacity if the interpretation indicated the
presence of any of the following: pulmonary opacity, pulmonary infiltrate, pulmonary
consolidation, pneumonia, or bronchopneumonia.
2.3 Statistical Analysis
Descriptive statistics were used to summarize demographic and clinical characteristics of the
study population. Using CT scan as a criterion standard, we calculated the sensitivity,
specificity, positive predictive value (PPV), negative predictive value (NPV), and
corresponding binomial 95% confidence intervals (CIs) of CXR for detection of pulmonary
opacities. Additionally, Cohen’s kappa and standard error were calculated to describe the
level of agreement between CXR and CT scan for detection of opacities. Statistical analyses
were performed with Stata 11.1 (Stata Corp, College Station, TX).
3. Results
During the study period, 4,237 subjects underwent a chest CT scan; 3,423 (80.8%) of these
subjects also had a CXR completed and were included in the final analyses (Fig 1).
Demographic and clinical characteristics of these subjects are summarized in Table 1.
Shortness of breath, chest pain and cough were the most common presenting complaints,
with 96.1% of subjects reporting at least one of these symptoms.
Pulmonary opacities were visualized on 309 (9.0%) CXRs and 191 (5.6 %) CT scans. The
diagnostic test characteristics of CXR for detection of pulmonary opacities using CT as a
criterion standard are displayed in Table 2. In this population with a 5.6% prevalence of
opacities on CT, the PPV of CXR—the probability of opacities visualized on CXR also
being seen on CT—was only 26.9% (95% CI: 22.1% – 32.2%). The sensitivity of CXR—the
probability of opacities detected on CT also being seen on CXR—was 43.5% (95% CI:
36.4% – 50.8%) Overall, agreement between CXR and CT was 90.2% (95% CI: 89.2 –
91.2%), with 6.6% (95% CI: 5.8–7.5%) of all patients having an opacity noted on CXR but
not CT, and 3.2% (95% CI: 2.6–3.8%) of all patients having an opacity detected on CT but
not CXR. Cohen’s kappa comparing CXR and CT for detection of pulmonary opacities was
0.28 (standard error: 0.017).
4. Discussion
From the standpoint of maximizing diagnostic accuracy, an optimal strategy for diagnosing
pneumonia would involve culturing specimens obtained from the lower respiratory tract.
However, due to the invasive nature of collecting these specimens and the time lapse needed
for cultures to grow, this strategy is not practical. Therefore, the standard for diagnosing
pneumonia that has developed over the past several decades involves recognition of a
syndrome of clinical, laboratory and radiographic features compatible with pulmonary
infection.3, 10
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Currently, CXR is the standard radiographic test used to evaluate for pneumonia.3 CT is a
more precise technique for imaging the chest, but is not routinely used to evaluate for
pneumonia due to greater cost, increased time required to obtain images, and higher
radiation exposure.11–13 The goal of this investigation was to evaluate the accuracy of CXR
compared to a concurrent CT for demonstrating pulmonary opacities in order to help
clinicians interpret the significance of CXR findings when considering a diagnosis of
pneumonia. We found substantial discordance with respect to detection of pulmonary
opacities between CXR and chest CT as interpreted by radiologists viewing the studies for
routine clinical care. Only 43.5% of patients with opacities on CT had opacities noted on
CXR. Furthermore, CXR findings interpreted as pulmonary opacities were frequently not
reproduced on concurrent CT; only 26.9% of patients with a CXR interpreted as having
pulmonary opacities had opacities recognized on CT.
These findings suggest CXR results cannot independently rule-in or rule-out pneumonia.
Patients with a presentation highly suspicious for bacterial pneumonia but without
pulmonary opacities visualized on CXR may benefit from further diagnostic testing, close
observation, or empiric antibiotic therapy to prevent patient harm from unrecognized
pneumonia. Similarly, patients with nonspecific CXR opacities but without clinical features
suggestive of pulmonary infection should not be reflexively diagnosed with pneumonia and
treated with antibiotics. In this study of adult ED patients presenting with acute
cardiopulmonary symptoms, 6.6% of patients had pulmonary opacities interpreted on CXR
that were not reproduced on CT. Considering the 12.4 million ED visits annually in the US
due to shortness of breath, chest pain or cough,16 an “opacity equals antibiotics” reflexive
management strategy is likely to lead to frequent overuse of antibiotics and unnecessary
pressure for the development of antibiotic resistance. Moreover, misattributing clinical signs
and symptoms, such as hypoxia or chest pain, to pneumonia based solely on CXR
appearance may result in failure to identify the true cause of these signs and symptoms.
Similar to our results, previous small studies in other populations have found CT to be more
sensitive than CXR for radiographic findings of pneumonia. In a prospective study of 58
hospitalized, bedridden patients, Esayaget al17 found CXR to be 65% sensitive for findings
of pneumonia compared to concurrent CT. Syrjala et al13 prospectively studied 47 patients
with clinical features of respiratory infection and found radiographic evidence of pneumonia
in 38% of patients on CXR compared to 55% on concurrent CT. Hayden and
Wrenn18retrospectively reviewed 97 ED patients diagnosed with pneumonia who underwent
both CXR and CT; 27% of these patients had opacities visualized on CT but not CXR.
Heusselet al19 prospectively studied the use of CT to evaluate for pneumonia in 188 patients
with neutropenic fever and a normal CXR; 60% of these patients had CT findings of
pneumonia.
Higher sensitivity of CT compared to CXR is likely attributable to enhanced visualization of
chest cavity regions not well imaged with CXR, such as the lung bases and lingula, as well
as thin, three-dimensional CT images detecting opacities too small to appreciate on
CXR.11, 13 The phenomenon of CXR findings interpreted as pulmonary opacities not being
reproduced on concurrent CT has not been well characterized. Transient atelectasis, shallow
inspiration or poor patient positioning during CXR imaging may contribute to CXRs falsely
appearing to contain pulmonary opacities, but further study is needed to understand the
prevalence and etiology of this phenomenon.
Due to the limitations of CXR for demonstrating signs of pulmonary infection, future
research is needed to investigate alternative and supplemental strategies to diagnose
pneumonia. Chest CT provides detailed radiographic images of the lungs and appears to
have higher sensitivity and specificity compared to CXR for pulmonary changes caused by
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pneumonia. Although CT is not currently an appropriate test to routinely assess for
pneumonia, the risk-to-benefit ratio may favor using CT to evaluate for pneumonia in
selected clinical scenarios, such as in the management of critically ill patients or to delineate
between alternative diagnoses that can produce similar abnormalities on CXR. Given the
limitations of CXR and our current strategy to diagnose pneumonia in the ED, development
of biomarkers and clinical decision rules has the potential to greatly improve diagnostic
algorithms for pneumonia.
4.1. Limitations
The study was nested within a larger study investigating risk factors for pulmonary
embolism. This nested design was chosen for practical considerations—the pulmonary
embolism study cohort provided a large, multicenter sample of ED patients with acute
cardiopulmonary symptoms who underwent both CXR and chest CT. Due to overlap in
signs and symptoms of pneumonia and pulmonary embolism, we believe this was a relevant
population to study for a preliminary comparison of CXR and CT for the detection of
opacities. However, prevalence of opacities in this study was relatively low and the
operating characteristics for CXR detection of opacities may be different in other
populations with higher prevalence. We analyzed CXR and CT interpretations from
radiologists working in real-world, clinical environments. This maximized applicability of
study results to ED clinicians, but also introduced limitations from a study design
perspective. Radiologists were not blinded to prior radiographic studies; when interpreting a
CT scan, radiologists were able to review CXRs completed earlier in the patient’s ED
course. This lack of blinding may have been a source of bias toward concordance between
CXR and CT. Furthermore, each radiographic study was interpreted by only one radiologist,
and the inter-rater reliability among different radiologists in the study was not measured.
5. Conclusion
In this multicenter cohort of adult ED patients with acute cardiopulmonary symptoms
evaluated with both CXR and chest CT, 9.8% of patients had discordant findings on CXR
and CT with respect to the presence of pulmonary opacities as interpreted by radiologists.
Using chest CT as a criterion standard for pulmonary opacities, CXR demonstrated poor
sensitivity and positive predictive value. Reliance on CXR to identify pneumonia may lead
to significant rates of misdiagnosis. Further research is indicated to investigate alternative
and supplemental strategies to diagnose pneumonia in the ED setting.
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Figure 1.
Flow diagram of patient enrollment and classification according to chest x-ray (CXR) and
chest computed tomography (CT) findings. ED: emergency department; CT: computed
tomography; CXR: chest x-ray.
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Table 1
Demographic and clinical characteristics of study participants.
Characteristic Subjects with pulmonary
opacities on CT scan
(n = 191)
Subjects without pulmonary
opacities on CT scan
(n = 3232)
Demographics
     Median age, years (IQR) 54 (41 – 66) 52 (39–65)
     Females, no (%) 112 (58.6%) 2172 (67.2%)
Race
     White, no (%) 116 (60.7%) 1894 (58.6%)
     Black, percent (%) 59 (30.9%) 1100 (34.0%)
     Other, percent (%) 16 (8.4%) 238 (7.4%)
Chronic medical conditions
     Coronary artery disease, no (%) 25 (13.1%) 390 (12.1%)
     Heart Failure, no (%) 21 (11.0%) 279 (8.6%)
     Hypertension, no (%) 72 (37.7%) 1330 (41.2%)
     Asthma, no (%) 30 (15.7%) 384 (11.9%)
     COPD, no (%) 32 (16.8%) 289 (8.9%)
     Diabetes mellitus, no (%) 32 (16.8%) 459 (14.2%)
     Renal disease on dialysis, no (%) 7 (3.7%) 48 (1.5%)
     Prior stroke, no (%) 11 (5.8%) 142 (4.4%)
     Active malignancy, no (%) 13 (6.8%) 295 (9.1%)
     Current smoker, no (%) 51 (26.7%) 680 (21.0%)
     BMI > 30, no (%) 62 (32.5%) 1182 (36.6%)
Symptoms
     Shortness of breath, no (%) 155 (81.2%) 2437 (75.4%)
     Chest pain, no (%) 118 (61.8%) 2255 (69.8%)
     Cough, no (%) 106 (55.5%) 1053 (32.6%)
Vital sign abnormalities*
     Temperature > 100.4°F, no (%) 21 (11.0%) 152 (4.7%)
     Heart Rate > 100 / min, no (%) 101 (52.9%) 1137 (35.2%)
     Oxygen saturation < 95%, no (%) 86 (45.0%) 809 (25.0%)
     Respiratory rate > 24/min, no (%) 77 (40.3%) 817 (25.3%)
Disposition from ED
     Discharge, no (%) 58 (30.4%) 1276 (39.5%)
     Admit obs or general ward, no (%) 120 (62.8%) 1839 (56.9%)
     Admit ICU, no (%) 11 (5.8%) 93 (2.9%)
*Vital sign abnormalities represent the most extreme values recorded during a subject’s emergency department course.
IQR: interquartile range; no: number; COPD: chronic obstructive pulmonary disease; BMI: body mass index; ED: emergency department; obs:
observation; ICU: intensive care unit.
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Table 2
Test characteristics of chest x-ray (CXR) for detection of pulmonary opacities compared to a chest computed
tomography (CT) criterion standard among 3,423 symptomatic adult emergency department patients.
Point estimate (%) 95% CI (%)
Prevalence of pulmonary opacities on CT 5.6 4.8 – 6.4
CXR sensitivity 43.5 36.4 – 50.8
CXR specificity 93.0 92.1 – 93.9
CXR positive predictive value 26.9 22.1 – 32.2
CXR negative predictive value 96.5 95.8 – 97.1
CI: confidence interval; CT: computed tomography; CXR: chest x-ray.
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